top of page
Industry
First research completed on the whole-life toxicity of CBD
Canopy Growth Corporation and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term...
Canopy Growth
Nov 20, 20201 min read
New Approaches for Incorporating Genetic Diversity into Toxicity Testing
Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed...
NIH
Jun 3, 20201 min read
bottom of page